Literature DB >> 22391401

Developing evidence-based immunization recommendations and GRADE.

P Duclos1, D N Durrheim, A L Reingold, Z A Bhutta, K Vannice, H Rees.   

Abstract

The Strategic Group of Advisory Experts (SAGE) on immunization is an independent advisory committee with a mandate to advise the World Health Organization (WHO) on the development of vaccine and immunization related policies. SAGE working groups are established on a time-limited basis to review and provide evidence-based recommendations, together with their implications, for open deliberation and decision-making by SAGE. In making its recommendations, SAGE takes into consideration: the epidemiologic and clinical characteristics of the disease; vaccine and immunization characteristics; economic analysis; health system considerations; the existence of and interaction with other intervention and control strategies; costing and social impacts; and legal and ethical concerns. Since 1998, WHO has produced evidence-based vaccine position papers for use primarily by national public health officials and immunization programme managers. Since April 2006 all new or updated position papers have been based on SAGE recommendations. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach has been adopted by WHO and, since 2008, GRADE tables that rate the quality of evidence have been produced in support of key recommendations. SAGE previously expressed concern that GRADE was not ideally suited to many immunization-specific issues such as the vaccine population level effect and the inclusion of surveillance system data, particularly for vaccine safety. Extensive productive interactions with various advisory groups including the US Advisory Committee on Immunization Practices, the European Centres for Disease Control, the German Standing Committee on Vaccination (STIKO), WHO's Global Advisory Committee on Vaccine Safety and the GRADE working group resulted in key enhancements to accommodate vaccine-relevant evidence. This facilitated integration and acceptability of the GRADE approach in the development of immunization related SAGE and WHO recommendations. Ongoing utilisation should result in further fine-tuning of the approach to ensure that recommendations are based on the full range of appropriate evidence.
Copyright © 2012 World Health Organization. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22391401     DOI: 10.1016/j.vaccine.2012.02.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Ethical considerations for vaccination programmes in acute humanitarian emergencies.

Authors:  Keymanthri Moodley; Kate Hardie; Michael J Selgelid; Ronald J Waldman; Peter Strebel; Helen Rees; David N Durrheim
Journal:  Bull World Health Organ       Date:  2013-02-07       Impact factor: 9.408

Review 2.  Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.

Authors:  Edwin J Asturias; Melinda Wharton; Robert Pless; Noni E MacDonald; Robert T Chen; Nicholas Andrews; David Salisbury; Alexander N Dodoo; Kenneth Hartigan-Go; Patrick L F Zuber
Journal:  Vaccine       Date:  2016-05-16       Impact factor: 3.641

Review 3.  The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.

Authors:  Yvonne Deleré; Ole Wichmann; Stefanie J Klug; Marianne van der Sande; Martin Terhardt; Fred Zepp; Thomas Harder
Journal:  Dtsch Arztebl Int       Date:  2014-09-01       Impact factor: 5.594

4.  Influenza vaccines licensed in the United States in healthy children: a systematic review and network meta-analysis (Protocol).

Authors:  Gabriela J Prutsky; Juan Pablo Domecq; Tarig Elraiyah; Zhen Wang; Lisa A Grohskopf; Larry J Prokop; Victor M Montori; Mohammad Hassan Murad
Journal:  Syst Rev       Date:  2012-12-29

Review 5.  Current experience with applying the GRADE approach to public health interventions: an empirical study.

Authors:  Eva A Rehfuess; Elie A Akl
Journal:  BMC Public Health       Date:  2013-01-08       Impact factor: 3.295

Review 6.  Strong Public Health Recommendations from Weak Evidence? Lessons Learned in Developing Guidance on the Public Health Management of Meningococcal Disease.

Authors:  Germaine Hanquet; Pawel Stefanoff; Wiebke Hellenbrand; Sigrid Heuberger; Pierluigi Lopalco; James M Stuart
Journal:  Biomed Res Int       Date:  2015-11-26       Impact factor: 3.411

7.  Revised Global Typhoid Vaccination Policy.

Authors:  Adwoa D Bentsi-Enchill; Joachim Hombach
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 20.999

8.  The National Immunization Technical Advisory Group in Israel.

Authors:  Chen Stein-Zamir; Shmuel Rishpon
Journal:  Isr J Health Policy Res       Date:  2021-01-26

9.  Application of the screening and indirect cohort methods to evaluate the effectiveness of pneumococcal vaccination program in adults 75 years and older in Taiwan.

Authors:  Wei-Ju Su; Pei-Hung Chuang; Luan-Yin Chang; Hsiu-Yun Lo; Chuen-Sheue Chiang; Ez-Tzu Wang; Chin-Hui Yang
Journal:  BMC Infect Dis       Date:  2021-01-10       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.